The Limited Times

Now you can see non-English news...

Clalit Health Insurance Fund presents: Artificial intelligence will detect chronic diseases | Israel Today

2020-11-27T10:52:57.056Z


| Developments and innovation"The use of artificial intelligence in medical imaging to prevent chronic diseases in large populations is the new frontier in medicine," said Dr. Arnon Makori, director of the imaging department at Clalit Health Services. • The technology will identify early risk of heart events. Photo: Yehoshua Yosef Clalit Health Fund is the first in Israel to implement artificial intelligence-based solution


"The use of artificial intelligence in medical imaging to prevent chronic diseases in large populations is the new frontier in medicine," said Dr. Arnon Makori, director of the imaging department at Clalit Health Services. • The technology will identify early risk of heart events.

  • Photo: Yehoshua Yosef

Clalit Health Fund is the first in Israel to implement artificial intelligence-based solutions in a wide deployment in the cloud by Zebra Medical Vision.

Using the technology, the fund's insured will be able to detect chronic diseases before there is advanced manifestation of the disease, by cross-referencing data with the existing image database in the fund's system.

In recent years, the research collaboration between Zebra Medical Vision and Clalit Public Health Services has led to a number of achievements - such as early detection of osteoporosis using a cloud-based algorithm for calculating bone density and early detection of osteoporotic fractures and risk of heart events from existing imaging tests. Extra or waste of time for the patient).

These days the partnership is expanding nationwide and will also benefit the public with a revolutionary solution in the field of mammography.

The Moore Institute will integrate Zebra Medical's solution in the second reading of mammograms and will be the first medical center in the country to use artificial intelligence in this test, in contrast to the current procedure where each test is deciphered by one specialist. 

The originality and uniqueness of the technology of the two companies is expressed in the early detection of osteoporosis using a cloud-based algorithm for calculating bone density, and early detection of osteoporotic fractures from existing imaging tests.

The move to the cloud and the assimilation of artificial intelligence will streamline the work processes of all parties involved: radiologists, attending physicians and patient service.

The company also states that the information will be obtained by the family doctor of the insured.

Zebra Medical Vision's algorithms work on the world's largest medical imaging database that allows it to produce a wide product basket that includes six FDA - approved solutions.

Also, a number of the company's solutions are already embedded in Canon Medical Systems US imaging machines, and are in use in hospitals around the world.

"Clalit Health Fund has changed the face of medicine and the health care system in Israel and is undoubtedly a leader in innovation in the management of the population's health in the community," says Ohad Arazi, CEO of Zebra Medical Vision.

"We welcome the fact that we have been selected to be Clalit's partners in its journey to become the first HMO in the world to implement AI solutions for medical imaging and improving the quality of care for its policyholders." 

"We at Clalit believe that prevention is better than cure," added Dr. Arnon Makori, director of the imaging department at Clalit Health Services.

'The use of artificial intelligence in medical imaging to prevent chronic diseases in large populations is the new frontier in medicine.

"Such a large-scale maximum implementation in a large organization requires durable and stable solutions and a close partnership that marches Clalit towards the most advanced era of medicine in the world."

Source: israelhayom

All tech articles on 2020-11-27

You may like

Trends 24h

Tech/Game 2024-03-27T18:05:36.686Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.